Skip to main content
  • Late Stent Events Linked to Response to Clopidogrel, Not ASA Longer-term trial data suggests limited value to platelet reactivity testing

    High platelet reactivity on aspirin (ASA) isn’t tied to worse outcomes, while clopidogrel (Plavix) resistance contributes to ischemic events more than 1 year after percutaneous coronary intervention (PCI), extended results of the ADAPT-DES study showed.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details